Titan Medical Inc is a leading medical device company that prides itself on its core values and corporate philosophy. With a strong commitment to innovation, excellence, and patient-centricity, Titan Medical Inc strives to revolutionize surgical procedures through its advanced robotic technologies. The company's unwavering dedication to providing safe, precise, and minimally invasive solutions has earned it a notable reputation in the healthcare industry. With a focus on enhancing patient outcomes and reducing healthcare costs, Titan Medical Inc aims to redefine the future of surgical robotics, making it a trustworthy and promising investment option in the stock market.

Titan Medical Inc is primarily present in the United States and Canada.

Titan Medical Inc has achieved several significant milestones. In 2018, the company received clearance from the FDA to initiate a clinical feasibility study for its SPORT Surgical System. In the following year, Titan Medical secured key patents related to the unique functionality and design of its robotic surgical system. Additionally, the company successfully completed its first-in-human surgical procedures using the SPORT Surgical System in 2019. These milestones demonstrate Titan Medical's commitment to innovation and highlight its progress in advancing robotic surgical technology.

Titan Medical Inc is a Canadian healthcare company that focuses on the development of robotic surgical technologies. Founded in 2008, Titan Medical aims to revolutionize minimally invasive surgery by creating advanced robotic systems. The company's flagship product is the Enos robotic surgical system, designed to assist surgeons with precise, efficient, and reliable surgical procedures. With a dedicated team of experts and strategic collaborations, Titan Medical remains committed to pioneering innovative solutions for the medical field. Continually driven by the goal of enhancing patient outcomes and surgical capabilities, Titan Medical Inc stands as a leading player in the evolving field of robotic surgery.

The main competitors of Titan Medical Inc in the market are Intuitive Surgical Inc, TransEnterix Inc, and Medtronic Inc.

Titan Medical Inc is primarily active in the healthcare and medical technology industries.

The business model of Titan Medical Inc is focused on developing robotic surgical technologies. The company aims to provide minimally invasive surgical solutions that can enhance patient outcomes, improve surgeon capabilities, and optimize healthcare costs. Titan Medical Inc is dedicated to advancing its Single Port Robotic Surgery System, which allows surgeons to perform procedures using a single incision. By leveraging innovative robotic technology, the company strives to revolutionize the field of robotic surgery and establish itself as a leader in the medical device industry.

Pašreizējais KGV Titan Medical nevar tikt aprēķināts.

KUV šobrīd Titan Medical nevar aprēķināt.

AlleAktien kvalitātes vērtējums Titan Medical ir 4/10.

Pašreiz nevar aprēķināt apgrozījumu Titan Medical.

Pašlaik peļņa Titan Medical nevar tikt aprēķināta.

Titan Medical Inc. is a company specializing in the development of robotic surgical systems. The company is based in Canada and is listed on the TSX-V and OTCQX. Titan Medical's goal is to improve and facilitate the performance of minimally invasive surgeries by offering innovative technologies and products. Titan Medical's business model includes the development, manufacturing, and marketing of robotic surgical systems. The company's system is called the SPORT (Single Port Orifice Robotic Technology) Surgical System, which is characterized by its single-port design and modular robot architecture. The SPORT platform is designed to support a variety of minimally invasive surgical procedures. In addition, Titan Medical aims to establish partnerships with other companies and organizations. One key partnership is with Medtronic, a global provider of medical devices. This collaboration aims to integrate Medtronic devices and instruments with the SPORT platform and expand the number of supported surgical procedures. Furthermore, Titan Medical also provides additional services to offer comprehensive support to its customers. These services include training, technical support, and customized solutions. The company aims to ensure that doctors and medical professionals can use the SPORT platform optimally and achieve the best possible results for their patients. Titan Medical strives to maintain a strong competitive advantage by continuously improving and innovating its products and services. The company invests continuously in research and development to develop new technologies and products. It also works closely with leading surgeons and other medical professionals to gather feedback and insights on the needs of patients and healthcare personnel. The strategic focus of Titan Medical also takes into account market needs and trends in healthcare. The company has recognized the increasing demand for minimally invasive surgical procedures in recent years and expects it to continue to rise. In this context, Titan Medical has a clear market positioning and is exploring new opportunities in various aspects of healthcare. Overall, Titan Medical's business model is focused on driving innovation and progress in the field of minimally invasive surgery. By developing innovative products, establishing new partnerships, and providing additional services, Titan Medical contributes to improving treatment outcomes and maximizing the patient experience.

Titan Medical izmaksā dividendes 0 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Titan Medical vai uzņēmums nedod dividendes.

Titan Medical ISIN ir CA88830X8199.

Titan Medical WKN ir A2JN66.

Titan Medical simbols ir TMD.TO.

Pēdējo 12 mēnešu laikā Titan Medical maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos Titan Medical plāno maksāt dividendes 0 USD apmērā.

Titan Medical pašreizējā dividendu rentabilitāte ir .

Titan Medical maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

Titan Medical pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 USD. Tas atbilst dividendes ražībai 0 %.

Titan Medical tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Titan Medical apmērā 0 USD, kas tika izmaksāta 8.10.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 8.10.2024..

Pēdējās dividendes izmaksa notika 8.10.2024..

Gadā 2023, Titan Medical izmaksāja 0 USD dividendes.

Titan Medical dividendes tiek izmaksātas USD.